Results 211 to 220 of about 1,959,636 (236)

Comparative analysis of central nervous system persistence of morbilliviruses across host species reveals shared features with subacute sclerosing panencephalitis. [PDF]

One Health Outlook
de Swart RL, de Vries RD.
europepmc   +1 more source

Engineering Antigen Density on M13 Bacteriophage for Personalized Nanovaccine

Advanced Healthcare Materials, EarlyView.
Increasing antigen density on the phage capsid impacts phage uptake and antigen cross‐presentation by antigen‐presenting cells, leading to enhanced activation of antitumor CD8+ T cells in the draining lymph nodes. These activated CD8+ T cells subsequently recognize the antigen‐expressing tumors and mediate their specific cytotoxic killing, thereby ...
Shengnan Huang, Allison Madow, Jack Rudrum, Huaiyao Peng, Hao Nghi Luu, Peiyan Dong, Jifa Qi, Angela M. Belcher   +7 more
wiley   +1 more source

Detection, characterization, and evolutionary inferences regarding a novel virus identified in Amblyomma dissimile Koch, 1844 (Acari: Ixodidae) from the Amazon, Pará, Brazil. [PDF]

Arch Virol
da Silva E Silva LH, da Silva SP, de Castro PHG, Maurício KD, da Silva FS, Dias DD, Hernández LHA, da Silva SLS, Reis HCF, Dos Santos LEC, do Nascimento BLS, Brandão RCF, Vieira DBR, Nunes BTD, Cruz ACR, Nunes Neto JP.   +15 more
europepmc   +1 more source

Measuring Blood Plasma Glutamine Levels Using a Nanopore‐Based Sensor

Advanced Healthcare Materials, EarlyView.
Glutamine (GLN) is a biomarker useful for predicting toxic ammonia accumulation. Here, we used a biosensor based on the Cytolysin A (ClyA) nanopore coupled with the GLN‐specific protein substrate‐binding domain 2 (SBD2) to demonstrate real‐time measurement of GLN in blood plasma, highlighting the potential for future point‐of‐care applications ...
Sofia B. Relvas, Iris M. Kormelink, Sandra Michel‐Souzy, Florian L. R. Lucas, Nieck J. van der Heide, Hans R. Waterham, Ramon Versteeg, Judith Jans, Loes I. Segerink, Carsten Wloka   +9 more
wiley   +1 more source

Advanced Materials for Biologics Delivery to Brain Tumors

Advanced Materials, EarlyView.
Material innovation is central to unlocking the therapeutic potential of biologics against many central nervous system diseases, including brain cancer. By engineering carriers with controlled transport, targeting, and release properties, advanced materials can overcome the blood–brain barrier and tumor microenvironment, improving the delivery of ...
Yuran Feng, Yuxue Cao, Maria Kavallaris, Taskeen Janjua, Amirali Popat   +4 more
wiley   +1 more source

Whole-Genome Sequencing of Measles Virus from 2025 Outbreak, Texas, USA. [PDF]

Emerg Infect Dis
Juntawong P, Oh B, Bovio R, Lu J, Stanley S, Potter RF, Sun Y, Schroeder C, Smith OA, Huebner E, White SL, Rai S, Shetty V, Kubin G.   +13 more
europepmc   +1 more source

Biomass DNA: An Emerging Building Block for Advanced Materials

Advanced Materials, EarlyView.
Biomass DNA is rapidly emerging from its traditional role as a genetic blueprint to serve as a versatile abundant, highly programmable polymeric building block. This review highlights the transformation of macroscopic bulk biomass DNA into next generation of functional materials, spanning from dynamic hydrogels, sustainable bioplastics, and high ...
Yuwei Hu, Itamar Willner, Li Niu
wiley   +1 more source

Cell culture medium influences RSV G protein glycosylation and recognition by monoclonal antibodies. [PDF]

Virol J
Engling N, Knittler MC, Tagore R, Ludlow M, Osterhaus ADME, Rimmelzwaan GF, Meineke R.   +6 more
europepmc   +1 more source